The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of glucagon in the possible mechanism of cardiovascular mortality reduction in type 2 diabetes patients

Published:2018-10-08 Issue:12 Volume:72 Page:e13274
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Skelin Marko¹^ORCID,Javor Eugen²,Lucijanić Marko³,Lucijanić Tomo⁴,Jakupović Lejsa⁵,Rahelić Dario⁴⁶

Affiliation:

1. Department of Pharmacy; General Hospital Šibenik; Šibenik Croatia

2. Department of Pharmacy; Sestre Milosrdnice University Hospital Center; Zagreb Croatia

3. Department of Hematology; Dubrava University Hospital; Zagreb Croatia

4. Department of Endocrinology, Diabetes and Clinical Pharmacology; Dubrava University Hospital; Zagreb Croatia

5. Healthcare Institution of Community Pharmacy Slavonski Brod; Slavonski Brod Croatia

6. School of Medicine; University of Zagreb; Zagreb Croatia

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.13274/fullpdf

Reference82 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

2. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

3. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients;Ferrannini;J Clin Invest,2014

4. The impact of chronic liraglutide therapy on glucagon secretion in type 2 diabetes: insight from the LIBRA trial;Kramer;J Clin Endocrinol Metab,2015

5. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidity progression analysis: patient stratification and comorbidity prediction using temporal comorbidity network;Health Information Science and Systems;2024-09-12

2. From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity;Endocrine Connections;2024-04-03

3. Glucagon and cardiovascular disease;Journal of Diabetology;2023

4. The economic impact of a clinical pharmacist’s involvement in the hospital medicines policy in a rural area;International Journal of Clinical Practice;2021-09-20

5. Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy;International Journal of Environmental Research and Public Health;2020-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3